Search Results
Search results for "Dongbo Bu"
Results found for "Dongbo Bu"
- How Lipid Rafts Organize GPCR Signaling | Dr. GPCR Ecosystem
to teach pharmacy and continue GPCR research at an institute for higher education, where his group built GRK2 and GRK3 differ - 10:16 The phosphorylation deficient receptor that desensitized better - 13:00 Building
- Nicole Perry-Hauser | Dr. GPCR Ecosystem
Nicole Perry-Hauser About Nicole (Nicki) Perry-Hauser I am a postdoctoral research fellow endeavoring to build
- Lauren Solano: Mapping Careers Beyond the Bench | Dr. GPCR Ecosystem
invisible to bench scientists, ranging from medical science liaison and clinical research roles to business
- Conformational Biosensors for GPCR Activation| Dr. GPCR Ecosystem
Intended for scientists with a working knowledge of GPCR pharmacology who use, or plan to build, cell-based first author of a 2026 Nature study that used genetic code expansion and bioorthogonal labeling to build
- Debbie Hay: Class B GPCRs, RAMPs, and the Migraine Pharmacology Gap | Dr. GPCR Ecosystem
Burning Curiosity as the Non-Negotiable Hay's advice to junior scientists distills to a single criterion Reproducibility, target validation, and the cost of science that cannot be repeated 34:53 Career advice - burning , deep drive still to get over those failures and pick yourself up, and that's a strong enough fire burning
- Leadership, Impact, and GPCR Signaling with Dr. Michelle Halls | Dr. GPCR Ecosystem
under real experimental constraints, Tried to map signaling heterogeneity in disease-relevant models, Built Her recognitions include the 2024 ASCEPT Achievement Award, the 2023 BPS Geoffrey Burnstock Prize, and Scientific Journey From Pipettes to Platforms: The Evolution of GPCR Research How GPCR Collaboration Built
- Qing Fan: Inside the Architecture of Class C GPCRs | Dr. GPCR Ecosystem
heterodimerization and the inter-subunit latch to an unexpected discovery of phospholipids inside the transmembrane bundle conformation, leading to an unexpected discovery: phospholipids embedded inside each transmembrane bundle Phospholipids inside the transmembrane bundle: a discovery nobody expected When Fan's team solved the cavity of each TM bundle. of each TM bundle."
- Murat Tunaboylu & Ben Holland | Dr. GPCR Ecosystem
After switching to biotech, Murat has built cell imaging software and lab robots to accelerate cancer
- From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation | Dr. GPCR Ecosystem
to predict signaling bias The entrepreneurial lessons no one tells postdocs: how to pitch, fail, and build He’s a strong advocate for cross-disciplinary thinking, mentoring young scientists, and building companies
- Sam Hoare: Receptor Residence Time and GPCR Data Analysis | Dr. GPCR Ecosystem
That discovery became the foundation of a career built on the data most pharmacologists generate but The Neurocrin team had to confront an explanation no assay had been designed to find — and then built GPCR Theory Was Built to Be Used One of Hoare's recurring arguments is that GPCRs are unusually tractable The practical knowledge of what buffer conditions work, what assay artifacts to expect, what the literature pharmacologists skip 01:45:04 Biased agonism and residence time as tools in the drug discovery toolbox 01:52:09 Building
- Antony Boucard: Adhesion GPCRs and the Molecular Code of Synapse Formation | Dr. GPCR Ecosystem
and a GPCR share a black widow spider toxin binding site — on adhesion GPCRs, synapse formation, and building Boucard Laboratory at the National Autonomous University of Mexico (UNAM) in Mexico City, where he has built Chef's Table Season 2 43:45 Time, focus, and the discipline of 15 minutes a day 52:38 Why Mexico City: building
- Irfan Dhanidina, Dr. Kathleen Caron and Dr. Lauren Slosky | Dr. GPCR Ecosystem
after insightful experiences in academic, hospital, and industry labs, I decided to pursue a role in business In my role at Orion Biotechnology, I work at the intersection of science and business, which includes target selection, preclinical strategy and business development. Caron has received numerous awards including a Burroughs Wellcome Fund Career Award in the Biomedical Program in Neuroscience, and Life Sciences Summer Undergraduate Research Program and is working to build
- Graciela Piñeyro: Partial Agonism, Receptor Recycling, and the Limits of Bias | Dr. GPCR Ecosystem
quantitative model turned her artifacts into real pharmacological responses, the throughline has never been building Piñeyro's answer is blunt: she does not think of herself as having built a career. I was not building a career. I was simply following my interests." About this episode Dr.
- GPCR Pharmacology, Career Twists & Serendipity with Sokhom Pin | Dr. GPCR Ecosystem
Sokhom Pin shares how he built a biotech career around GPCRs, designed a custom PhD path, and led teams I was trusted to build a team from scratch.” He built what others called the “happiest team at Alkermes,” showing that joy and scientific rigor aren
- Kathryn Livingston: Allosteric Opioid Modulators and Receptor Signaling Beyond the Membrane | Dr. GPCR Ecosystem
postdocs considering industry Selected Quotes "Instead of directly targeting the receptor like morphine or buprenorphine
- The Scientist's Compass: From Academia to Entrepreneurship with Dr. Dmitry Veprintsev | Dr. GPCR Ecosystem
Building Z7 Biotech – The unexpected journey into biotech entrepreneurship, providing GPCR profiling
- Fiona Marshall: Three Decades Inside GPCR Drug Discovery | Dr. GPCR Ecosystem
Brown sitting with a table of actives and inactives — was that the active condition was the acetate buffer set a career in motion 07:07 A venture capital visit to the LMB and the founding of Heptares 11:28 Building ignoring GPCRs 36:39 The GABA-B heterodimer — the moment baclofen finally worked 40:06 The acetate-in-the-buffer
- A Brief History of allosteric modulation with Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
Arthur highlighted his mentors' influence, such as Fred Mitchelson and Nigel Burch, and significant discoveries Arthur shared his career journey, including his collaboration with Patrick Sexton and Jim Burch, and early papers related to the topic, including work by Brian Roth, Terry Kenakin, Bill Clarke, and Kelly Burke
- Maria Waldhoer: Pharmacological Fingerprints and the Limits of Bias | Dr. GPCR Ecosystem
InterAx treats GPCR pharmacology the way engineers treat aircraft design: build the mathematical model Young founders should not build alone.
- EARNEST Panel: Can AI Accelerate GPCR Drug Discovery? | Dr. GPCR Ecosystem
is not machine learning, and neither is simple computational modeling) to the practical realities of building An MD-PhD who has practiced machine learning since 1989, he built Pharos, the public-facing data platform Buffers, incubation temperatures, time points, co-expression conditions, the specific Emax reference
- Xylazine, Fentanyl, and the Fight for Breath with Catherine Demery | Dr. GPCR Ecosystem
designing preclinical models of fentanyl and xylazine overdose, she reflects on staying in academia, building What You’ll Learn in This Episode How industry lab experience builds the discipline needed for academic
- Team Access to Terry’s Pharmacology Corner | 25% Group Discount | Dr. GPCR Ecosystem
Activation typically takes 3–10 business days . Need to add members later? Explore : Foundational Lessons — Build Your Pharmacology Core Emerging Drug Hunter — Expand Your Edge
- Model. Predict. Discover. with Dr. Jens Carlsson | Dr. GPCR Ecosystem
structural biology—and where it still falls short Advice for junior scientists: what really matters when building That moment launched a career built around using computational tools to answer big biological questions Jens is passionate about prediction over explanation: building models that can guide experiments, not
- Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar | Dr. GPCR Ecosystem
Ilana Kotliar built a multiplexed platform to map GPCR-RAMP interactions and uncover autoantibody-driven She expanded the original Family B focus to encompass the entire GPCR superfamily , building a digital
- Chemical Probes for GPCR Imaging and Internalization with Dr. Johannes Broichhagen | Dr. GPCR Ecosystem
Johannes Broichhagen shares how his lab builds next-generation fluorescent probes to visualize GPCRs Tried to build assays that behave in living cells—not just on paper.
- Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem
Aaron Sato on building the synthetic antibody library that finally makes GPCRs tractable — and the greenfield This conversation explores how synthetic antibody phage display libraries, built on silicon-based DNA For Aaron, this work is personal: he has built his career hunting greenfield targets where others had His current focus is building synthetic phage display libraries that drug targets the field has long
- Robert J. Lefkowitz: Beta-Adrenergic Receptors, the GPCR Family, and Fifty Years of Discovery | Dr. GPCR Ecosystem
And I remember thinking to myself as a young buck at the time: I'm going to show this guy.
- Anita Nivedha: Computational Dynamics of Ligand Bias in GPCR Signaling | Dr. GPCR Ecosystem
led him into GPCR research, drug discovery, and membrane protein biology—plus practical insights on building
- Eleonora Comeo: Fluorescent Ligands and the Pharmacology of Adenosine Receptors | Dr. GPCR Ecosystem
For Comeo, who entered GPCR research without any background in the field and built her PhD around chemistry
- Dr. GPCR Board | Dr. GPCR Ecosystem
After a well needed break from the grind, I am now a scientific/business consultant for clients both






























